Beyond the Bolus Blog for Healthcare Providers
Automated insulin delivery (AID) has increasingly become the standard of care for people with type 1 diabetes, driven by strong evidence of improved glycemic results. The RADIANT trial1 is the first randomized study to evaluate a tubeless AID system—Omnipod® 5—versus multiple daily
The ADA Standards of Care1, the gold standard in evidence-based guidelines, are updated annually through the efforts of its Professional Practice Committee for diabetes.
Categories
The author has been compensated for this article.